TAKHZYRO (LANADELUMAB-FLYO) — FDA Approval BLA761090 (DYAX CORP.)
TAKHZYRO (LANADELUMAB-FLYO) — FDA Approval BLA761090 (DYAX CORP.) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TAKHZYRO; Active ingredients: LANADELUMAB-FLYO; Application number: BLA761090.
| Brand name | TAKHZYRO |
|---|---|
| Active ingredients | LANADELUMAB-FLYO |
| Application number | BLA761090 |
| Sponsor | DYAX CORP. |
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20180823 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →